NEW YORK (360Dx) – OraSure Technologies announced after the close of the market on Wednesday an 8 percent year-over-year increase in its second quarter revenues on strong international sales of its OraQuick HIV testing products.

For the three-month period ended June 30, OraSure's revenues rose to $43.6 million from $40.2 million in the same quarter last year, topping Wall Street's consensus estimate of $42.2 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 


In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.


Sponsored by

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.